Global
Contact Us
DKSH Japan participated in the “JAIMA Summer Science School 2026”, engaging students in a hands-on nanoparticle measurement workshop using advanced nanoparticle tracking analysis technology. The initiative highlighted the role of science and technology in addressing societal challenges and reflects DKSH’s commitment to empowering future scientists through STEM education.
DKSH has signed an agreement to acquire the Meliane oral contraceptive brand from Bayer across 30 markets in Europe, North Africa, Asia, and the Middle East. The acquisition is in line with DKSH’s strategy to expand its Healthcare Own Brands portfolio and strengthen its presence in higher-value segments and services.
Corrigendum to the ad hoc announcement of 17 July 2026: EPS in H1 2026 was CHF 1.56 (not CHF 1.67), representing growth of 10.6% compared to H1 2025 (not 18.2%). The full text of the corrected announcement is as follows: Net sales of CHF 5.5 billion (+4.9% at CER1) Core EBIT of CHF 163.4 million (+3.6% at CER) Core EBIT margin of 3.0% Increase of Earnings per share (EPS) by 10.6% to CHF 1.56 Free Cash Flow of CHF 147.7 million (130.8% cash conversion rate) Three acquisitions announced in H1 2026 and good pipeline for H2 Stronger H2 expected: improving commercial momentum, data center project pipeline and M&A potential Mid-term roadmap confirmed
Net sales of CHF 5.5 billion (+4.9% at CER1) Core EBIT of CHF 163.4 million (+3.6% at CER) Core EBIT margin of 3.0% Increase of Earnings per share (EPS) by 18.2% to CHF 1.67 Free Cash Flow of CHF 147.7 million (130.8% cash conversion rate) Three acquisitions announced in H1 2026 and good pipeline for H2 Stronger H2 expected: improving commercial momentum, data center project pipeline and M&A potential Mid-term roadmap confirmed
DKSH has achieved another industry-leading milestone by receiving the AA MSCI ESG Rating. This improved rating, advancing from “A” to “AA,” positions DKSH in the prestigious “Leader” category. The recognition highlights DKSH’s strong performance in responsible business practices and its ongoing commitment to sustainable growth.
DKSH has closed an agreement to acquire the business of Kinematic Resources Sdn. Bhd. (“Kinematic”), a leading Malaysian distributor of high-value scientific and analytical instruments in Malaysia. With this transaction, DKSH Technology further scales its operations in Malaysia in line with the Business Unit’s strategy to solidify its position as a leading scientific solutions provider in Asia and Beyond.
At the Extraordinary General Meeting (“EGM”) that was held today in Kuala Lumpur, Malaysia, the minority shareholders of DKSH Holdings (Malaysia) Berhad (“DHMB”) have rejected the take-over offer that DKSH Holding Ltd. (“DKSH”) submitted through its subsidiaries.
Shareholders approved all motions with a clear majority Reelection of the current Board members seeking another term as well as the Chairman of the Board of Directors Election of three new Board members, establishing a female majority on the Board of Directors Proposal of dividend increase of 6.4% to CHF 2.50 per share accepted
DKSH announced today the signing of an agreement to acquire AIC Ingredients, a Malaysia-based manufacturer of functional food ingredients with a leading position in the Malaysian bakery sector. This strategic move significantly strengthens the position of DKSH Performance Materials in the highly attractive and growing market of tailored functional ingredients across Southeast Asia.
Reach out to our Group Media Relations team for any inquiries.
Manager, Group Media Relations
Contact us to discover new opportunities.